NO992985D0 - Anvendelse av COMT inhibitorer for fremstilling av et legemiddel til Õ forhindre diabetisk vaskulµr dysfunksjon - Google Patents

Anvendelse av COMT inhibitorer for fremstilling av et legemiddel til Õ forhindre diabetisk vaskulµr dysfunksjon

Info

Publication number
NO992985D0
NO992985D0 NO992985A NO992985A NO992985D0 NO 992985 D0 NO992985 D0 NO 992985D0 NO 992985 A NO992985 A NO 992985A NO 992985 A NO992985 A NO 992985A NO 992985 D0 NO992985 D0 NO 992985D0
Authority
NO
Norway
Prior art keywords
drug
manufacture
comt inhibitors
vascular dysfunction
diabetic vascular
Prior art date
Application number
NO992985A
Other languages
English (en)
Norwegian (no)
Other versions
NO992985L (no
Inventor
Anita Chatarina Aperia
Inge-Britt Yvonne Linden
Original Assignee
Orion Yhtymae Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oyj filed Critical Orion Yhtymae Oyj
Publication of NO992985L publication Critical patent/NO992985L/no
Publication of NO992985D0 publication Critical patent/NO992985D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO992985A 1996-12-20 1999-06-17 Anvendelse av COMT inhibitorer for fremstilling av et legemiddel til Õ forhindre diabetisk vaskulµr dysfunksjon NO992985D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9626472.6A GB9626472D0 (en) 1996-12-20 1996-12-20 New use of comt inhibitors
PCT/FI1997/000812 WO1998027973A1 (en) 1996-12-20 1997-12-19 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions

Publications (2)

Publication Number Publication Date
NO992985L NO992985L (no) 1999-06-17
NO992985D0 true NO992985D0 (no) 1999-06-17

Family

ID=10804746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992985A NO992985D0 (no) 1996-12-20 1999-06-17 Anvendelse av COMT inhibitorer for fremstilling av et legemiddel til Õ forhindre diabetisk vaskulµr dysfunksjon

Country Status (23)

Country Link
US (1) US6207706B1 (cs)
EP (1) EP0964678B1 (cs)
JP (1) JP2001507006A (cs)
KR (1) KR20000057628A (cs)
AT (1) ATE234613T1 (cs)
AU (1) AU714086B2 (cs)
BG (1) BG103491A (cs)
CA (1) CA2275681A1 (cs)
CZ (1) CZ291117B6 (cs)
DE (1) DE69720064D1 (cs)
EA (1) EA001673B1 (cs)
EE (1) EE9700350A (cs)
GB (1) GB9626472D0 (cs)
HU (1) HUP0001097A3 (cs)
IL (1) IL130500A (cs)
NO (1) NO992985D0 (cs)
NZ (1) NZ336043A (cs)
PL (1) PL334093A1 (cs)
SK (1) SK79999A3 (cs)
TR (1) TR199901206T2 (cs)
WO (1) WO1998027973A1 (cs)
YU (1) YU28599A (cs)
ZA (1) ZA9711468B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20000635A0 (fi) 2000-03-17 2000-03-17 Orion Yhtymae Oyj COMT-inhibiittoreiden käyttö analgeettina
FI20001593A7 (fi) * 2000-07-03 2002-01-04 Orion Yhtymo Oyj Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
FI20002044A0 (fi) 2000-09-15 2000-09-15 Orion Yhtymae Oyj Comt-entsyymiä estäviä naftaleenijohdannaisia
MY148644A (en) * 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds
TWI638802B (zh) 2012-05-24 2018-10-21 芬蘭商奧利安公司 兒茶酚o-甲基轉移酶活性抑制化合物
JP2021532133A (ja) 2018-07-25 2021-11-25 オリオン コーポレーション 4,5−ジヒドロキシ−2−(4−メチルベンジル)イソフタロニトリル溶媒和物およびその結晶形
JP2022506697A (ja) 2018-11-09 2022-01-17 オリオン コーポレーション 4,5-ジヒドロキシ-2-(4-メチルベンジル)イソフタロニトリルの製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672042A (en) 1981-12-21 1987-06-09 Orion Research Puerto Rico, Inc. Method of and apparatus for chromatographic analysis
US5236952A (en) * 1986-03-11 1993-08-17 Hoffmann-La Roche Inc. Catechol derivatives
DK175069B1 (da) 1986-03-11 2004-05-24 Hoffmann La Roche Pyrocatecholderivater
US5283352A (en) 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
YU213587A (en) 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
FI864875A0 (fi) 1986-11-28 1986-11-28 Orion Yhtymae Oy Nya farmakologiskt aktiva foereningar, dessa innehaollande kompositioner samt foerfarande och mellanprodukter foer anvaendning vid framstaellning av dessa.
US5489614A (en) 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
MTP1031B (en) * 1987-12-24 1990-10-04 Orion Yhtymae Oy New use of cathecol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
IL91382A (en) 1988-09-01 1995-06-29 Orion Yhtymae Oy Alkenyl or arylmethylene-substituted beta-diketones their preparation and pharmaceutical compositions containing them
US5185370A (en) 1988-09-01 1993-02-09 Orion-Yhtyma Oy Substituted β-diketones and their use
US5185332A (en) 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB9510481D0 (en) 1995-05-24 1995-07-19 Orion Yhtymae Oy New catechol derivatives

Also Published As

Publication number Publication date
US6207706B1 (en) 2001-03-27
ZA9711468B (en) 1998-08-29
EE9700350A (et) 1998-10-15
BG103491A (bg) 2000-04-28
CA2275681A1 (en) 1998-07-02
PL334093A1 (en) 2000-01-31
EA001673B1 (ru) 2001-06-25
TR199901206T2 (xx) 1999-08-23
EA199900579A1 (ru) 1999-12-29
WO1998027973A1 (en) 1998-07-02
NO992985L (no) 1999-06-17
DE69720064D1 (de) 2003-04-24
ATE234613T1 (de) 2003-04-15
KR20000057628A (ko) 2000-09-25
SK79999A3 (en) 2000-05-16
YU28599A (sh) 2002-03-18
EP0964678B1 (en) 2003-03-19
AU7871198A (en) 1998-07-17
IL130500A (en) 2003-02-12
JP2001507006A (ja) 2001-05-29
HUP0001097A3 (en) 2003-05-28
GB9626472D0 (en) 1997-02-05
EP0964678A1 (en) 1999-12-22
IL130500A0 (en) 2000-06-01
HUP0001097A2 (hu) 2000-09-28
NZ336043A (en) 2000-12-22
CZ223199A3 (cs) 1999-11-17
AU714086B2 (en) 1999-12-16
CZ291117B6 (cs) 2002-12-11

Similar Documents

Publication Publication Date Title
ATE234090T1 (de) Kombination von duloxetin mit nichtsteroid- entzündungshemmern für die behandlung von schmerz
ATE455560T1 (de) Topische zusammensetzungen enthaltend einen alpha 1-adrenergic blocker zur behandlung von schmerzhaften zuständen der analregion
DK1032376T3 (da) Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
CY1109972T1 (el) Χρηση τοξινης αλλαντιασης για τη θεραπευτικη αγωγη του πονου της νεραλγιας
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
DE60139466D1 (de) Behandlung von diabetes
EA199800139A1 (ru) Способ лечения аденомы толстой кишки
NO992985D0 (no) Anvendelse av COMT inhibitorer for fremstilling av et legemiddel til Õ forhindre diabetisk vaskulµr dysfunksjon
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
GB0020504D0 (en) Therapeutic method
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
SE9703929D0 (sv) Therapeutical use and method
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
ATE149840T1 (de) Behandlung von leberkrebs
NO20030841D0 (no) En ny spesifikk mekanisme for inhibering av blodplateadhesjon til kollagen
SI1003554T1 (en) Proton pump inhibitor in therapeutic combination with antibacterial substances
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
WO2002005796A3 (en) Use of a spla2 inhibitor for the treatment of sepsis
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
UA31754A (uk) Спосіб профілактики рецидивів меланоми шкіри
EA199800818A1 (ru) Способ лечения бессонницы

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application